对阿片类药物依赖的阿片类激素治疗中产后保留:基于人口的队列研究
Joanna Zhou1, Bianca Varney1,2, Nicola Jones1
1National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Archives of women's mental health
|January 6, 2026
概括
产后阿片类激素治疗 (OAT) 的保留率很高,但有所不同. 晚期开始OAT或有风险因素的妇女需要有针对性的支持. 布普伦诺啡因保留需要监测和量身定制的护理.
科学领域:
- 产科和妇科 产科和妇科
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
背景情况:
- 建议在产后对阿片类药物依赖进行阿片类激素治疗 (OAT).
- 关于产后OAT保留率的证据有限.
- 了解影响养的因素对于母亲和婴儿的福祉至关重要.
研究的目的:
- 为了检查产后OAT保留率.
- 为了确定与OAT保留相关的母性特征.
- 为阿片类药物依赖妇女提供有针对性的支持策略提供信息.
主要方法:
- 将OAT处方数据与澳大利亚新南威尔士州的围产和死亡记录联系起来.
- 在分娩期间 (2004-2020年) 接受OAT的女性.
- 使用通用线性建模计算产后90,180和365天的保留率.
主要成果:
- 观察到高保留率:93.3%在90天,88.4%在180天,和78.5%在365天.
- 在180天后,较低的保留时间与OAT晚期启动,土著身份,最近的监禁,布普伦诺芬治疗和精神疾病有关.
- 在产后90天和365天发现了类似的关联模式.
结论:
- 产后OAT保留率通常很高,但在子组之间显示出显著的差异.
- 对于在怀孕晚期开始OAT的妇女或具有社会/临床风险因素的妇女,需要有针对性的支持.
- 持续监测和针对布普伦诺芬治疗的量身定制护理是必不可少的,特别是当它是首选的第一线选择时.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
Opioid Analgesics: Morphine and Other Natural Cogeners
841
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
841
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
249
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
249


